Since 1915<\/h3><\/div>We are a fast-growing, Swiss-based pharmaceutical group<\/span><\/h1><\/div>acting as a commercial partner for innovative and specialty medicines in the emerging markets.<\/h1><\/div><\/div><\/div>who we are<\/span><\/a><\/div><\/div><\/div><\/div><\/div>Since 1915<\/h3><\/div>We are a fast-growing,
\nSwiss-based
\npharmaceutical group<\/span><\/h1><\/div>acting as a commercial partner for innovative and specialty medicines in the emerging markets.<\/h1><\/div>who we are<\/span><\/a><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>Our services<\/h3><\/div>We offer biopharmaceutical innovators a high-value, end-to-end commercialization partnership across emerging markets. Leveraging our unique expertise and geographic footprint, we help bring innovative and specialty medicines to patients in need.<\/p>\n<\/div><\/div><\/div>
<\/span><\/a><\/span>COMMERCIAL PARTNERSHIPS<\/h4><\/div>Our partners are top biotech firms with innovative products and global expansion goals.<\/p>\n<\/div><\/i><\/div><\/div><\/span><\/a><\/span>MANAGED ACCESS:
\nNAME PATIENT PROGRAMMES<\/h4><\/div>We set up paid market access programmes for innovative specialty medicines.<\/p>\n<\/div><\/i><\/div><\/div><\/span><\/a><\/span>MEDICINES SHORTAGES IN HOSPITALS<\/h4><\/div>Despite efforts, drug shortages strain healthcare, risking patient care and forcing pharmacists to find alternatives.<\/p>\n<\/div><\/i><\/div><\/div><\/div><\/div>Latest news<\/h3><\/div><\/div><\/div>Read all<\/span><\/a><\/div><\/div><\/div>FarmaMondo Group expands reach with the launch of FarmaMondo India PVT. LTD.<\/a><\/h4><\/div>FarmaMondo Group is proud to announce the opening of its new office in Mumbai, India- marking their 13th global location across six key regions.<\/p><\/div>
2 March 2026<\/p>\n<\/div>
Read more<\/span><\/a><\/div><\/div><\/li>\nFarmaMondo Group and Kedrion Biopharma Announce Exclusive Partnership Agreement for Coagadex\u00ae distribution in the Baltics<\/a><\/h4><\/div>FarmaMondo Group and Kedrion Biopharma announced an exclusive agreement to distribute Coagadex\u00ae (human coagulation factor X) across Estonia, Latvia, and Lithuania.<\/p><\/div>
1 October 2025<\/p>\n<\/div>
Read more<\/span><\/a><\/div><\/div><\/li>\nFarmaMondo Group Expands Existing Partnership with Recordati Rare Diseases to Distribute Enjaymo (Sultimlimab-jome)<\/a><\/h4><\/div>Farma Mondo Group Expands Existing Partnership with Recordati Rare Diseases, Signing Exclusive Agreement to Distribute Enjaymo (Sultimlimab-jome) in countries where the product is not commercially available.<\/p><\/div>
18 September 2025<\/p>\n<\/div>
Read more<\/span><\/a><\/div><\/div><\/li>\n<\/ul><\/div><\/div><\/div><\/div><\/div><\/div>We are proud to serve as the one-stop commercial partner for innovators seeking to expand into emerging markets. For millions of patients, we provide hope where no one else does.<\/h4><\/div>Yaron Spigel, Group CEO<\/p>\n<\/div><\/div><\/div><\/div><\/div>
<\/div>We are proud to serve as <\/b>the one-stop commercial partner for innovators seeking to expand into emerging markets. For millions of patients, we provide hope where no one else does.<\/h4><\/div>Yaron Spigel, Group CEO<\/p>\n<\/div><\/div><\/div><\/div><\/div>
Our values<\/h3><\/div>FarmaMondo cares about patient needs.<\/strong><\/p>\n<\/div><\/div><\/div>Act responsibly<\/h3><\/div><\/div><\/div>Collaborate with trust<\/h3><\/div><\/div><\/div>Commit to patient access<\/h3><\/div><\/div><\/div>Operate with excellence<\/h3><\/div><\/div><\/div><\/div><\/div><\/span><\/a><\/span>Our team is here to help you for further questions and any information.<\/p>\n<\/div><\/div><\/div>
contact us<\/span><\/a><\/div><\/div><\/div><\/div><\/div><\/div>
We are a fast-growing, Swiss-based pharmaceutical group<\/span><\/h1><\/div>acting as a commercial partner for innovative and specialty medicines in the emerging markets.<\/h1><\/div><\/div><\/div>who we are<\/span><\/a><\/div><\/div><\/div><\/div><\/div>Since 1915<\/h3><\/div>We are a fast-growing,
\nSwiss-based
\npharmaceutical group<\/span><\/h1><\/div>acting as a commercial partner for innovative and specialty medicines in the emerging markets.<\/h1><\/div>who we are<\/span><\/a><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>Our services<\/h3><\/div>We offer biopharmaceutical innovators a high-value, end-to-end commercialization partnership across emerging markets. Leveraging our unique expertise and geographic footprint, we help bring innovative and specialty medicines to patients in need.<\/p>\n<\/div><\/div><\/div>
<\/span><\/a><\/span>COMMERCIAL PARTNERSHIPS<\/h4><\/div>Our partners are top biotech firms with innovative products and global expansion goals.<\/p>\n<\/div><\/i><\/div><\/div><\/span><\/a><\/span>MANAGED ACCESS:
\nNAME PATIENT PROGRAMMES<\/h4><\/div>We set up paid market access programmes for innovative specialty medicines.<\/p>\n<\/div><\/i><\/div><\/div><\/span><\/a><\/span>MEDICINES SHORTAGES IN HOSPITALS<\/h4><\/div>Despite efforts, drug shortages strain healthcare, risking patient care and forcing pharmacists to find alternatives.<\/p>\n<\/div><\/i><\/div><\/div><\/div><\/div>Latest news<\/h3><\/div><\/div><\/div>Read all<\/span><\/a><\/div><\/div><\/div>FarmaMondo Group expands reach with the launch of FarmaMondo India PVT. LTD.<\/a><\/h4><\/div>FarmaMondo Group is proud to announce the opening of its new office in Mumbai, India- marking their 13th global location across six key regions.<\/p><\/div>
2 March 2026<\/p>\n<\/div>
Read more<\/span><\/a><\/div><\/div><\/li>\nFarmaMondo Group and Kedrion Biopharma Announce Exclusive Partnership Agreement for Coagadex\u00ae distribution in the Baltics<\/a><\/h4><\/div>FarmaMondo Group and Kedrion Biopharma announced an exclusive agreement to distribute Coagadex\u00ae (human coagulation factor X) across Estonia, Latvia, and Lithuania.<\/p><\/div>
1 October 2025<\/p>\n<\/div>
Read more<\/span><\/a><\/div><\/div><\/li>\nFarmaMondo Group Expands Existing Partnership with Recordati Rare Diseases to Distribute Enjaymo (Sultimlimab-jome)<\/a><\/h4><\/div>Farma Mondo Group Expands Existing Partnership with Recordati Rare Diseases, Signing Exclusive Agreement to Distribute Enjaymo (Sultimlimab-jome) in countries where the product is not commercially available.<\/p><\/div>
18 September 2025<\/p>\n<\/div>
Read more<\/span><\/a><\/div><\/div><\/li>\n<\/ul><\/div><\/div><\/div><\/div><\/div><\/div>We are proud to serve as the one-stop commercial partner for innovators seeking to expand into emerging markets. For millions of patients, we provide hope where no one else does.<\/h4><\/div>Yaron Spigel, Group CEO<\/p>\n<\/div><\/div><\/div><\/div><\/div>
<\/div>We are proud to serve as <\/b>the one-stop commercial partner for innovators seeking to expand into emerging markets. For millions of patients, we provide hope where no one else does.<\/h4><\/div>Yaron Spigel, Group CEO<\/p>\n<\/div><\/div><\/div><\/div><\/div>
Our values<\/h3><\/div>FarmaMondo cares about patient needs.<\/strong><\/p>\n<\/div><\/div><\/div>Act responsibly<\/h3><\/div><\/div><\/div>Collaborate with trust<\/h3><\/div><\/div><\/div>Commit to patient access<\/h3><\/div><\/div><\/div>Operate with excellence<\/h3><\/div><\/div><\/div><\/div><\/div><\/span><\/a><\/span>Our team is here to help you for further questions and any information.<\/p>\n<\/div><\/div><\/div>
contact us<\/span><\/a><\/div><\/div><\/div><\/div><\/div><\/div>
acting as a commercial partner for innovative and specialty medicines in the emerging markets.<\/h1><\/div><\/div><\/div>who we are<\/span><\/a><\/div><\/div><\/div><\/div><\/div>Since 1915<\/h3><\/div>We are a fast-growing,
\nSwiss-based
\npharmaceutical group<\/span><\/h1><\/div>acting as a commercial partner for innovative and specialty medicines in the emerging markets.<\/h1><\/div>who we are<\/span><\/a><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>Our services<\/h3><\/div>We offer biopharmaceutical innovators a high-value, end-to-end commercialization partnership across emerging markets. Leveraging our unique expertise and geographic footprint, we help bring innovative and specialty medicines to patients in need.<\/p>\n<\/div><\/div><\/div>
<\/span><\/a><\/span>COMMERCIAL PARTNERSHIPS<\/h4><\/div>Our partners are top biotech firms with innovative products and global expansion goals.<\/p>\n<\/div><\/i><\/div><\/div><\/span><\/a><\/span>MANAGED ACCESS:
\nNAME PATIENT PROGRAMMES<\/h4><\/div>We set up paid market access programmes for innovative specialty medicines.<\/p>\n<\/div><\/i><\/div><\/div><\/span><\/a><\/span>MEDICINES SHORTAGES IN HOSPITALS<\/h4><\/div>Despite efforts, drug shortages strain healthcare, risking patient care and forcing pharmacists to find alternatives.<\/p>\n<\/div><\/i><\/div><\/div><\/div><\/div>Latest news<\/h3><\/div><\/div><\/div>Read all<\/span><\/a><\/div><\/div><\/div>FarmaMondo Group expands reach with the launch of FarmaMondo India PVT. LTD.<\/a><\/h4><\/div>FarmaMondo Group is proud to announce the opening of its new office in Mumbai, India- marking their 13th global location across six key regions.<\/p><\/div>
2 March 2026<\/p>\n<\/div>
Read more<\/span><\/a><\/div><\/div><\/li>\nFarmaMondo Group and Kedrion Biopharma Announce Exclusive Partnership Agreement for Coagadex\u00ae distribution in the Baltics<\/a><\/h4><\/div>FarmaMondo Group and Kedrion Biopharma announced an exclusive agreement to distribute Coagadex\u00ae (human coagulation factor X) across Estonia, Latvia, and Lithuania.<\/p><\/div>
1 October 2025<\/p>\n<\/div>
Read more<\/span><\/a><\/div><\/div><\/li>\nFarmaMondo Group Expands Existing Partnership with Recordati Rare Diseases to Distribute Enjaymo (Sultimlimab-jome)<\/a><\/h4><\/div>Farma Mondo Group Expands Existing Partnership with Recordati Rare Diseases, Signing Exclusive Agreement to Distribute Enjaymo (Sultimlimab-jome) in countries where the product is not commercially available.<\/p><\/div>
18 September 2025<\/p>\n<\/div>
Read more<\/span><\/a><\/div><\/div><\/li>\n<\/ul><\/div><\/div><\/div><\/div><\/div><\/div>We are proud to serve as the one-stop commercial partner for innovators seeking to expand into emerging markets. For millions of patients, we provide hope where no one else does.<\/h4><\/div>Yaron Spigel, Group CEO<\/p>\n<\/div><\/div><\/div><\/div><\/div>
<\/div>We are proud to serve as <\/b>the one-stop commercial partner for innovators seeking to expand into emerging markets. For millions of patients, we provide hope where no one else does.<\/h4><\/div>Yaron Spigel, Group CEO<\/p>\n<\/div><\/div><\/div><\/div><\/div>
Our values<\/h3><\/div>FarmaMondo cares about patient needs.<\/strong><\/p>\n<\/div><\/div><\/div>Act responsibly<\/h3><\/div><\/div><\/div>Collaborate with trust<\/h3><\/div><\/div><\/div>Commit to patient access<\/h3><\/div><\/div><\/div>Operate with excellence<\/h3><\/div><\/div><\/div><\/div><\/div><\/span><\/a><\/span>Our team is here to help you for further questions and any information.<\/p>\n<\/div><\/div><\/div>
contact us<\/span><\/a><\/div><\/div><\/div><\/div><\/div><\/div>
Since 1915<\/h3><\/div>We are a fast-growing,
\nSwiss-based
\npharmaceutical group<\/span><\/h1><\/div>acting as a commercial partner for innovative and specialty medicines in the emerging markets.<\/h1><\/div>who we are<\/span><\/a><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>Our services<\/h3><\/div>We offer biopharmaceutical innovators a high-value, end-to-end commercialization partnership across emerging markets. Leveraging our unique expertise and geographic footprint, we help bring innovative and specialty medicines to patients in need.<\/p>\n<\/div><\/div><\/div>
<\/span><\/a><\/span>COMMERCIAL PARTNERSHIPS<\/h4><\/div>Our partners are top biotech firms with innovative products and global expansion goals.<\/p>\n<\/div><\/i><\/div><\/div><\/span><\/a><\/span>MANAGED ACCESS:
\nNAME PATIENT PROGRAMMES<\/h4><\/div>We set up paid market access programmes for innovative specialty medicines.<\/p>\n<\/div><\/i><\/div><\/div><\/span><\/a><\/span>MEDICINES SHORTAGES IN HOSPITALS<\/h4><\/div>Despite efforts, drug shortages strain healthcare, risking patient care and forcing pharmacists to find alternatives.<\/p>\n<\/div><\/i><\/div><\/div><\/div><\/div>Latest news<\/h3><\/div><\/div><\/div>Read all<\/span><\/a><\/div><\/div><\/div>FarmaMondo Group expands reach with the launch of FarmaMondo India PVT. LTD.<\/a><\/h4><\/div>FarmaMondo Group is proud to announce the opening of its new office in Mumbai, India- marking their 13th global location across six key regions.<\/p><\/div>
2 March 2026<\/p>\n<\/div>
Read more<\/span><\/a><\/div><\/div><\/li>\nFarmaMondo Group and Kedrion Biopharma Announce Exclusive Partnership Agreement for Coagadex\u00ae distribution in the Baltics<\/a><\/h4><\/div>FarmaMondo Group and Kedrion Biopharma announced an exclusive agreement to distribute Coagadex\u00ae (human coagulation factor X) across Estonia, Latvia, and Lithuania.<\/p><\/div>
1 October 2025<\/p>\n<\/div>
Read more<\/span><\/a><\/div><\/div><\/li>\nFarmaMondo Group Expands Existing Partnership with Recordati Rare Diseases to Distribute Enjaymo (Sultimlimab-jome)<\/a><\/h4><\/div>Farma Mondo Group Expands Existing Partnership with Recordati Rare Diseases, Signing Exclusive Agreement to Distribute Enjaymo (Sultimlimab-jome) in countries where the product is not commercially available.<\/p><\/div>
18 September 2025<\/p>\n<\/div>
Read more<\/span><\/a><\/div><\/div><\/li>\n<\/ul><\/div><\/div><\/div><\/div><\/div><\/div>We are proud to serve as the one-stop commercial partner for innovators seeking to expand into emerging markets. For millions of patients, we provide hope where no one else does.<\/h4><\/div>Yaron Spigel, Group CEO<\/p>\n<\/div><\/div><\/div><\/div><\/div>
<\/div>We are proud to serve as <\/b>the one-stop commercial partner for innovators seeking to expand into emerging markets. For millions of patients, we provide hope where no one else does.<\/h4><\/div>Yaron Spigel, Group CEO<\/p>\n<\/div><\/div><\/div><\/div><\/div>
Our values<\/h3><\/div>FarmaMondo cares about patient needs.<\/strong><\/p>\n<\/div><\/div><\/div>Act responsibly<\/h3><\/div><\/div><\/div>Collaborate with trust<\/h3><\/div><\/div><\/div>Commit to patient access<\/h3><\/div><\/div><\/div>Operate with excellence<\/h3><\/div><\/div><\/div><\/div><\/div><\/span><\/a><\/span>Our team is here to help you for further questions and any information.<\/p>\n<\/div><\/div><\/div>
contact us<\/span><\/a><\/div><\/div><\/div><\/div><\/div><\/div>
We are a fast-growing,
\nSwiss-based
\npharmaceutical group<\/span><\/h1><\/div>acting as a commercial partner for innovative and specialty medicines in the emerging markets.<\/h1><\/div>who we are<\/span><\/a><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>Our services<\/h3><\/div>We offer biopharmaceutical innovators a high-value, end-to-end commercialization partnership across emerging markets. Leveraging our unique expertise and geographic footprint, we help bring innovative and specialty medicines to patients in need.<\/p>\n<\/div><\/div><\/div>
<\/span><\/a><\/span>COMMERCIAL PARTNERSHIPS<\/h4><\/div>Our partners are top biotech firms with innovative products and global expansion goals.<\/p>\n<\/div><\/i><\/div><\/div><\/span><\/a><\/span>MANAGED ACCESS:
\nNAME PATIENT PROGRAMMES<\/h4><\/div>We set up paid market access programmes for innovative specialty medicines.<\/p>\n<\/div><\/i><\/div><\/div><\/span><\/a><\/span>MEDICINES SHORTAGES IN HOSPITALS<\/h4><\/div>Despite efforts, drug shortages strain healthcare, risking patient care and forcing pharmacists to find alternatives.<\/p>\n<\/div><\/i><\/div><\/div><\/div><\/div>Latest news<\/h3><\/div><\/div><\/div>Read all<\/span><\/a><\/div><\/div><\/div>FarmaMondo Group expands reach with the launch of FarmaMondo India PVT. LTD.<\/a><\/h4><\/div>FarmaMondo Group is proud to announce the opening of its new office in Mumbai, India- marking their 13th global location across six key regions.<\/p><\/div>
2 March 2026<\/p>\n<\/div>
Read more<\/span><\/a><\/div><\/div><\/li>\nFarmaMondo Group and Kedrion Biopharma Announce Exclusive Partnership Agreement for Coagadex\u00ae distribution in the Baltics<\/a><\/h4><\/div>FarmaMondo Group and Kedrion Biopharma announced an exclusive agreement to distribute Coagadex\u00ae (human coagulation factor X) across Estonia, Latvia, and Lithuania.<\/p><\/div>
1 October 2025<\/p>\n<\/div>
Read more<\/span><\/a><\/div><\/div><\/li>\nFarmaMondo Group Expands Existing Partnership with Recordati Rare Diseases to Distribute Enjaymo (Sultimlimab-jome)<\/a><\/h4><\/div>Farma Mondo Group Expands Existing Partnership with Recordati Rare Diseases, Signing Exclusive Agreement to Distribute Enjaymo (Sultimlimab-jome) in countries where the product is not commercially available.<\/p><\/div>
18 September 2025<\/p>\n<\/div>
Read more<\/span><\/a><\/div><\/div><\/li>\n<\/ul><\/div><\/div><\/div><\/div><\/div><\/div>We are proud to serve as the one-stop commercial partner for innovators seeking to expand into emerging markets. For millions of patients, we provide hope where no one else does.<\/h4><\/div>Yaron Spigel, Group CEO<\/p>\n<\/div><\/div><\/div><\/div><\/div>
<\/div>We are proud to serve as <\/b>the one-stop commercial partner for innovators seeking to expand into emerging markets. For millions of patients, we provide hope where no one else does.<\/h4><\/div>Yaron Spigel, Group CEO<\/p>\n<\/div><\/div><\/div><\/div><\/div>
Our values<\/h3><\/div>FarmaMondo cares about patient needs.<\/strong><\/p>\n<\/div><\/div><\/div>Act responsibly<\/h3><\/div><\/div><\/div>Collaborate with trust<\/h3><\/div><\/div><\/div>Commit to patient access<\/h3><\/div><\/div><\/div>Operate with excellence<\/h3><\/div><\/div><\/div><\/div><\/div><\/span><\/a><\/span>Our team is here to help you for further questions and any information.<\/p>\n<\/div><\/div><\/div>
contact us<\/span><\/a><\/div><\/div><\/div><\/div><\/div><\/div>
acting as a commercial partner for innovative and specialty medicines in the emerging markets.<\/h1><\/div>who we are<\/span><\/a><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>Our services<\/h3><\/div>We offer biopharmaceutical innovators a high-value, end-to-end commercialization partnership across emerging markets. Leveraging our unique expertise and geographic footprint, we help bring innovative and specialty medicines to patients in need.<\/p>\n<\/div><\/div><\/div>
<\/span><\/a><\/span>COMMERCIAL PARTNERSHIPS<\/h4><\/div>Our partners are top biotech firms with innovative products and global expansion goals.<\/p>\n<\/div><\/i><\/div><\/div><\/span><\/a><\/span>MANAGED ACCESS:
\nNAME PATIENT PROGRAMMES<\/h4><\/div>We set up paid market access programmes for innovative specialty medicines.<\/p>\n<\/div><\/i><\/div><\/div><\/span><\/a><\/span>MEDICINES SHORTAGES IN HOSPITALS<\/h4><\/div>Despite efforts, drug shortages strain healthcare, risking patient care and forcing pharmacists to find alternatives.<\/p>\n<\/div><\/i><\/div><\/div><\/div><\/div>Latest news<\/h3><\/div><\/div><\/div>Read all<\/span><\/a><\/div><\/div><\/div>FarmaMondo Group expands reach with the launch of FarmaMondo India PVT. LTD.<\/a><\/h4><\/div>FarmaMondo Group is proud to announce the opening of its new office in Mumbai, India- marking their 13th global location across six key regions.<\/p><\/div>
2 March 2026<\/p>\n<\/div>
Read more<\/span><\/a><\/div><\/div><\/li>\nFarmaMondo Group and Kedrion Biopharma Announce Exclusive Partnership Agreement for Coagadex\u00ae distribution in the Baltics<\/a><\/h4><\/div>FarmaMondo Group and Kedrion Biopharma announced an exclusive agreement to distribute Coagadex\u00ae (human coagulation factor X) across Estonia, Latvia, and Lithuania.<\/p><\/div>
1 October 2025<\/p>\n<\/div>
Read more<\/span><\/a><\/div><\/div><\/li>\nFarmaMondo Group Expands Existing Partnership with Recordati Rare Diseases to Distribute Enjaymo (Sultimlimab-jome)<\/a><\/h4><\/div>Farma Mondo Group Expands Existing Partnership with Recordati Rare Diseases, Signing Exclusive Agreement to Distribute Enjaymo (Sultimlimab-jome) in countries where the product is not commercially available.<\/p><\/div>
18 September 2025<\/p>\n<\/div>
Read more<\/span><\/a><\/div><\/div><\/li>\n<\/ul><\/div><\/div><\/div><\/div><\/div><\/div>We are proud to serve as the one-stop commercial partner for innovators seeking to expand into emerging markets. For millions of patients, we provide hope where no one else does.<\/h4><\/div>Yaron Spigel, Group CEO<\/p>\n<\/div><\/div><\/div><\/div><\/div>
<\/div>We are proud to serve as <\/b>the one-stop commercial partner for innovators seeking to expand into emerging markets. For millions of patients, we provide hope where no one else does.<\/h4><\/div>Yaron Spigel, Group CEO<\/p>\n<\/div><\/div><\/div><\/div><\/div>
Our values<\/h3><\/div>FarmaMondo cares about patient needs.<\/strong><\/p>\n<\/div><\/div><\/div>Act responsibly<\/h3><\/div><\/div><\/div>Collaborate with trust<\/h3><\/div><\/div><\/div>Commit to patient access<\/h3><\/div><\/div><\/div>Operate with excellence<\/h3><\/div><\/div><\/div><\/div><\/div><\/span><\/a><\/span>Our team is here to help you for further questions and any information.<\/p>\n<\/div><\/div><\/div>
contact us<\/span><\/a><\/div><\/div><\/div><\/div><\/div><\/div>
Our services<\/h3><\/div>We offer biopharmaceutical innovators a high-value, end-to-end commercialization partnership across emerging markets. Leveraging our unique expertise and geographic footprint, we help bring innovative and specialty medicines to patients in need.<\/p>\n<\/div><\/div><\/div>
<\/span><\/a><\/span>COMMERCIAL PARTNERSHIPS<\/h4><\/div>Our partners are top biotech firms with innovative products and global expansion goals.<\/p>\n<\/div><\/i><\/div><\/div><\/span><\/a><\/span>MANAGED ACCESS:
\nNAME PATIENT PROGRAMMES<\/h4><\/div>We set up paid market access programmes for innovative specialty medicines.<\/p>\n<\/div><\/i><\/div><\/div><\/span><\/a><\/span>MEDICINES SHORTAGES IN HOSPITALS<\/h4><\/div>Despite efforts, drug shortages strain healthcare, risking patient care and forcing pharmacists to find alternatives.<\/p>\n<\/div><\/i><\/div><\/div><\/div><\/div>Latest news<\/h3><\/div><\/div><\/div>Read all<\/span><\/a><\/div><\/div><\/div>FarmaMondo Group expands reach with the launch of FarmaMondo India PVT. LTD.<\/a><\/h4><\/div>FarmaMondo Group is proud to announce the opening of its new office in Mumbai, India- marking their 13th global location across six key regions.<\/p><\/div>
2 March 2026<\/p>\n<\/div>
Read more<\/span><\/a><\/div><\/div><\/li>\nFarmaMondo Group and Kedrion Biopharma Announce Exclusive Partnership Agreement for Coagadex\u00ae distribution in the Baltics<\/a><\/h4><\/div>FarmaMondo Group and Kedrion Biopharma announced an exclusive agreement to distribute Coagadex\u00ae (human coagulation factor X) across Estonia, Latvia, and Lithuania.<\/p><\/div>
1 October 2025<\/p>\n<\/div>
Read more<\/span><\/a><\/div><\/div><\/li>\nFarmaMondo Group Expands Existing Partnership with Recordati Rare Diseases to Distribute Enjaymo (Sultimlimab-jome)<\/a><\/h4><\/div>Farma Mondo Group Expands Existing Partnership with Recordati Rare Diseases, Signing Exclusive Agreement to Distribute Enjaymo (Sultimlimab-jome) in countries where the product is not commercially available.<\/p><\/div>
18 September 2025<\/p>\n<\/div>
Read more<\/span><\/a><\/div><\/div><\/li>\n<\/ul><\/div><\/div><\/div><\/div><\/div><\/div>We are proud to serve as the one-stop commercial partner for innovators seeking to expand into emerging markets. For millions of patients, we provide hope where no one else does.<\/h4><\/div>Yaron Spigel, Group CEO<\/p>\n<\/div><\/div><\/div><\/div><\/div>
<\/div>We are proud to serve as <\/b>the one-stop commercial partner for innovators seeking to expand into emerging markets. For millions of patients, we provide hope where no one else does.<\/h4><\/div>Yaron Spigel, Group CEO<\/p>\n<\/div><\/div><\/div><\/div><\/div>
Our values<\/h3><\/div>FarmaMondo cares about patient needs.<\/strong><\/p>\n<\/div><\/div><\/div>Act responsibly<\/h3><\/div><\/div><\/div>Collaborate with trust<\/h3><\/div><\/div><\/div>Commit to patient access<\/h3><\/div><\/div><\/div>Operate with excellence<\/h3><\/div><\/div><\/div><\/div><\/div><\/span><\/a><\/span>Our team is here to help you for further questions and any information.<\/p>\n<\/div><\/div><\/div>
contact us<\/span><\/a><\/div><\/div><\/div><\/div><\/div><\/div>
We offer biopharmaceutical innovators a high-value, end-to-end commercialization partnership across emerging markets. Leveraging our unique expertise and geographic footprint, we help bring innovative and specialty medicines to patients in need.<\/p>\n<\/div><\/div><\/div>
COMMERCIAL PARTNERSHIPS<\/h4><\/div>Our partners are top biotech firms with innovative products and global expansion goals.<\/p>\n<\/div><\/i><\/div><\/div><\/span><\/a><\/span>MANAGED ACCESS:
\nNAME PATIENT PROGRAMMES<\/h4><\/div>We set up paid market access programmes for innovative specialty medicines.<\/p>\n<\/div><\/i><\/div><\/div><\/span><\/a><\/span>MEDICINES SHORTAGES IN HOSPITALS<\/h4><\/div>Despite efforts, drug shortages strain healthcare, risking patient care and forcing pharmacists to find alternatives.<\/p>\n<\/div><\/i><\/div><\/div><\/div><\/div>Latest news<\/h3><\/div><\/div><\/div>Read all<\/span><\/a><\/div><\/div><\/div>FarmaMondo Group expands reach with the launch of FarmaMondo India PVT. LTD.<\/a><\/h4><\/div>FarmaMondo Group is proud to announce the opening of its new office in Mumbai, India- marking their 13th global location across six key regions.<\/p><\/div>
2 March 2026<\/p>\n<\/div>
Read more<\/span><\/a><\/div><\/div><\/li>\nFarmaMondo Group and Kedrion Biopharma Announce Exclusive Partnership Agreement for Coagadex\u00ae distribution in the Baltics<\/a><\/h4><\/div>FarmaMondo Group and Kedrion Biopharma announced an exclusive agreement to distribute Coagadex\u00ae (human coagulation factor X) across Estonia, Latvia, and Lithuania.<\/p><\/div>
1 October 2025<\/p>\n<\/div>
Read more<\/span><\/a><\/div><\/div><\/li>\nFarmaMondo Group Expands Existing Partnership with Recordati Rare Diseases to Distribute Enjaymo (Sultimlimab-jome)<\/a><\/h4><\/div>Farma Mondo Group Expands Existing Partnership with Recordati Rare Diseases, Signing Exclusive Agreement to Distribute Enjaymo (Sultimlimab-jome) in countries where the product is not commercially available.<\/p><\/div>
18 September 2025<\/p>\n<\/div>
Read more<\/span><\/a><\/div><\/div><\/li>\n<\/ul><\/div><\/div><\/div><\/div><\/div><\/div>We are proud to serve as the one-stop commercial partner for innovators seeking to expand into emerging markets. For millions of patients, we provide hope where no one else does.<\/h4><\/div>Yaron Spigel, Group CEO<\/p>\n<\/div><\/div><\/div><\/div><\/div>
<\/div>We are proud to serve as <\/b>the one-stop commercial partner for innovators seeking to expand into emerging markets. For millions of patients, we provide hope where no one else does.<\/h4><\/div>Yaron Spigel, Group CEO<\/p>\n<\/div><\/div><\/div><\/div><\/div>
Our values<\/h3><\/div>FarmaMondo cares about patient needs.<\/strong><\/p>\n<\/div><\/div><\/div>Act responsibly<\/h3><\/div><\/div><\/div>Collaborate with trust<\/h3><\/div><\/div><\/div>Commit to patient access<\/h3><\/div><\/div><\/div>Operate with excellence<\/h3><\/div><\/div><\/div><\/div><\/div><\/span><\/a><\/span>Our team is here to help you for further questions and any information.<\/p>\n<\/div><\/div><\/div>
contact us<\/span><\/a><\/div><\/div><\/div><\/div><\/div><\/div>
Our partners are top biotech firms with innovative products and global expansion goals.<\/p>\n<\/div><\/i><\/div><\/div> We set up paid market access programmes for innovative specialty medicines.<\/p>\n<\/div><\/i><\/div><\/div> Despite efforts, drug shortages strain healthcare, risking patient care and forcing pharmacists to find alternatives.<\/p>\n<\/div><\/i><\/div><\/div><\/div><\/div> FarmaMondo Group is proud to announce the opening of its new office in Mumbai, India- marking their 13th global location across six key regions.<\/p><\/div> 2 March 2026<\/p>\n<\/div> FarmaMondo Group and Kedrion Biopharma announced an exclusive agreement to distribute Coagadex\u00ae (human coagulation factor X) across Estonia, Latvia, and Lithuania.<\/p><\/div> 1 October 2025<\/p>\n<\/div> Farma Mondo Group Expands Existing Partnership with Recordati Rare Diseases, Signing Exclusive Agreement to Distribute Enjaymo (Sultimlimab-jome) in countries where the product is not commercially available.<\/p><\/div> 18 September 2025<\/p>\n<\/div> Yaron Spigel, Group CEO<\/p>\n<\/div><\/div><\/div><\/div><\/div> Yaron Spigel, Group CEO<\/p>\n<\/div><\/div><\/div><\/div><\/div> FarmaMondo cares about patient needs.<\/strong><\/p>\n<\/div><\/div><\/div> Our team is here to help you for further questions and any information.<\/p>\n<\/div><\/div><\/div>MANAGED ACCESS:
\nNAME PATIENT PROGRAMMES<\/h4><\/div>MEDICINES SHORTAGES IN HOSPITALS<\/h4><\/div>
Latest news<\/h3><\/div><\/div><\/div>
FarmaMondo Group expands reach with the launch of FarmaMondo India PVT. LTD.<\/a><\/h4><\/div>
FarmaMondo Group and Kedrion Biopharma Announce Exclusive Partnership Agreement for Coagadex\u00ae distribution in the Baltics<\/a><\/h4><\/div>
FarmaMondo Group Expands Existing Partnership with Recordati Rare Diseases to Distribute Enjaymo (Sultimlimab-jome)<\/a><\/h4><\/div>
We are proud to serve as the one-stop commercial partner for innovators seeking to expand into emerging markets. For millions of patients, we provide hope where no one else does.<\/h4><\/div>
We are proud to serve as <\/b>the one-stop commercial partner for innovators seeking to expand into emerging markets. For millions of patients, we provide hope where no one else does.<\/h4><\/div>
Our values<\/h3><\/div>
Act responsibly<\/h3><\/div><\/div><\/div>
Collaborate with trust<\/h3><\/div><\/div><\/div>
Commit to patient access<\/h3><\/div><\/div><\/div>
Operate with excellence<\/h3><\/div><\/div><\/div><\/div><\/div>
![\"Vips](\"https:\/\/farmamondo.com\/wp-content\/uploads\/2025\/04\/logo-vips.webp\"){kind=logo}
<\/a><\/span><\/div><\/div><\/div>![\"Farma](\"https:\/\/farmamondo.com\/wp-content\/uploads\/2025\/03\/Farma-industria-ticino.png\")
<\/a><\/span><\/div><\/div><\/div><\/div><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"100-width.php","meta":{"footnotes":""},"class_list":["post-10","page","type-page","status-publish","hentry"],"yoast_head":"\n